Nepeta japonica Maximowicz extract from natural products inhibits lipid accumulation

Journal of the Science of Food and Agriculture

Volumn 92, Issue 10, 2012, Pages 2195-2199

  Roh, Changhyun ^a   Jung, Uhee ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Anti obesity; Lipid inhibition; Natural products; Nepeta japonica Maximowicz

Indexed keywords

ANTIOBESITY AGENT; GLYCEROL; PLANT EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; DRUG ANTAGONISM; DRUG EFFECT; LIPID METABOLISM; METABOLISM; MOUSE; NEPETA; OBESITY; PHYTOTHERAPY; SWINE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTI-OBESITY AGENTS; GLYCEROL; LIPASE; LIPID METABOLISM; MICE; NEPETA; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; SWINE; TRIGLYCERIDES;

JAPONICA; NEPETA; SUS;

EID: 84862219468     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.5608     Document Type: Article

References (19)

1. Velan SS, Said N, Durst C, Frisbee J, Raylman RR, Thomas MA, et al, Distinct patterns of fat metabolism in skeletal muscle of normal weight, overweight, and obese humans. Am J Physiol Reg I 295: R1060-R1065 (2008).
2. Visscher TL and Seidell JC, The public health impact of obesity. Annu Rev Pub Health 22: 355-375 (2001).
3. Yach D, Stuckler D and Brownell KD, Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12: 62-66 (2006).
4. O'Rahilly S, Farooqi IS, Yeo GS and Challis BG, Mini-review: Human obesity: Lessons from monogenic disorders. Endocrinology 144: 3757-3764 (2003).
5. Spiegelman BM and Flier JS, Obesity and the regulation of energy balance. Cell 104: 531-543 (2001).
6. Haslam DW and James WPT, Obesity. Lancet 366: 1197-1209 (2005).
7. Gesta S, Tseng YH and Kahn CR, Developmental origin of fat: Tracking obesity to its source. Cell 131: 242-256 (2007).
8. Buttriss JL, Hanging on the coat tails of the obesity epidemic: Will metabolic syndrome be the next public health crisis and does nutrition have a role in its prevention? J Sci Food Agric 86: 2285-2289 (2006).
9. Stavric B, Role of chemopreventers in human diet. Clin Biochem 27: 319-332 (1994).
10. Ballinger A and Peikin SR, Orlistat: Its current status as an anti-obesity drug. Eur J Pharmacol 440: 109-117 (2002).
11. Li MF and Cheung BMY, Rise and fall of anti-obesity drugs. World J Diabetes 15: 19-23 (2011).
12. Scheen AJ, Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc drugs 10: 321-334 (2010).
13. Xiwen L and Gangmu TB, Compendium of Materia Medica, vol. 6. Foreign Languages Press, Beijing (2003).
14. Unschuld PU, Medicine in China: A History of Pharmaceutics. University of California Press, Stanford (1986).
15. Kim YS, Lee YM, Kim H, Kim J, Jang DK, Kim JH, et al, Anti-obesity effect of Morus bombycis root extract: Anti-lipase activity and lipolytic effect. J Ethnopharmacol 130: 621-624, (2010).
16. Zheng CD, Duan YQ, Gao JM and Ruan ZG, Screening of anti-lipase properties of 37 traditional Chinese medicinal herbs. J Chin Med Assoc 73: 319-324 (2010).
17. 2-induced oxidative damage in HPF-1 cell by oxidized phenolic compounds present in black tea. Food Chem 105: 1349-1356 (2007).
18. Mcgowan MW, Artiss JD, Strandbergh DR and Zak B, A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29: 538-542 (1983).
19. De la Garza AL, Milagro FI, Boque N, Campion J and Martinez JA, Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med 77: 773-785 (2011).